Primary tumor location predicts poor clinical outcome with cetuximab in RAS wild-type metastatic colorectal cancer

BACKGROUND: In metastatic colorectal cancer, the location of the primary tumor has been suggested to have biological significance. In this study, we investigated whether primary tumor location affects cetuximab efficacy in patients with RAS wild-type metastatic colorectal cancer. METHODS: Genotyping...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:BMC Gastroenterol
Prif Awduron: Kim, Dalyong, Kim, Sun Young, Lee, Ji Sung, Hong, Yong Sang, Kim, Jeong Eun, Kim, Kyu-pyo, Kim, Jihun, Jang, Se Jin, Yoon, Young-Kwang, Kim, Tae Won
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2017
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5701369/
https://ncbi.nlm.nih.gov/pubmed/29169325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-017-0694-6
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg